| View Larger Image | Commercializing Successful Biomedical Technologies: Basic Principles for the Development of Drugs, Diagnostics and Devices | Hardcoverby Shreefal S. Mehta (Author)
| List Price: | $72.00 | | Price: | $57.60 | | You Save: | $14.40 (20%) | | | Available: | Usually ships in 24 hours |
| | Binding: | Hardcover | | Publisher: | Cambridge University Press | | Edition: | 1st Edition | | Page Count: | 360 Pages | | Publication Date: | June 02, 2008 | | Sales Rank: | 432,193nd |
|
EDITORIAL REVIEWS |
Product Description
Successful product design and development requires the ability to take a concept and translate the technology into useful, patentable, commercial products. This book guides the reader through the practical aspects of the commercialization process of drug, diagnostic and device biomedical technology including market analysis, product development, intellectual property and regulatory constraints. Key issues are highlighted at each stage in the process, and case studies are used to provide practical examples. The book will provide a sound road map for those involved in the biotechnology industry to effectively plan the commercialization of profitable regulated medical products. It will also be suitable for a capstone design course in engineering and biotechnology, providing the student with the business acumen skills involved in product development. |
CUSTOMER REVIEWS (Average Customer Rating: 5.0 based on 1 review)
|
Outstanding overview of the complexities of commercialization by L. Burnett  5 Stars
October 28, 2009
I am using this text in a commercializing biomaterials course and highly recommend it to graduate students and post-docs who want to enter the world of start-up biotechnology. I think it would also be very helpful to junior faculty who are thinking about commercializing their research. It is brilliantly constructed to walk you through the basics of taking your research from the bench to bedside and the challenges you are going to face along the way. I also found the author's use of vignettes and specific examples very helpful to illustrate complex points. This book won't write your business plan for you but should help you do your market analysis and give you the questions to ask when you initiate disclosures to your university's Technology Transfer office. Highly recommended.
| |
SIMILAR PRODUCTS |
| Best Practices in Biotechnology Business Development: Valuation, Licensing, Cash Flow, Pharmacoeconomics, Market Selection, Communication, and Intellectual Property
by Yali Friedman (Editor)
The biotechnology industry is growing rapidly. Every year increasing numbers of life science graduates enter the workforce, more researchers seek to commercialize their research findings, and growing numbers of biotechnology-minded business students and business professionals seek to apply their skills and knowledge to biotechnology. Some of these biotechnology workers enter existing companies, whereas others start their own companies. Regardless of their education, training, or the nature of...
| 
| Biodesign: The Process of Innovating Medical Technologies
by Stefanos Zenios (Author), Josh Makower (Author), Paul Yock (Author), Todd J. Brinton (Author), Uday N. Kumar (Author), Lyn Denend (Author), Thomas M. Krummel (Author)
Recognize market opportunities, master the design process, and develop business acumen with this 'how-to' guide to medical technology innovation. A three-step, proven approach to the biodesign innovation process - identify, invent, implement - provides a practical formula for innovation. The experiences of hundreds of innovators and companies, in the form of case studies, quotes and practical advice, offer a realistic, action-orientated roadmap for successful biodesign innovation. Real-world...
| 
| Biotechnology Valuation: An Introductory Guide (The Wiley Finance Series)
by Karl Keegan (Author)
* The first book to provide a simple and practical means of valuing biotech companies
* The book begins with a short history of the biotechnology industry; this is important as although it is about 30 years old, the first company went public only in 1996, so it is possible to plot the course of investment waves and dips
* It examines the European industry and its evolvement, and draws parallels between the similarities and differences between that and the US
* Looks at the...
| 
| Business Development for the Biotechnology and Pharmaceutical Industry
by Martin Austin (Author)
Business Development in the Biotechnology and pharmaceutical industries accounts for over $5 billion in licensing deal value per year and much more than that in the value of mergers and acquisitions. Transactions range from licences to patented academic research, to product developments as licences, joint ventures and acquisition of intellectual property rights, and on to collaborations in development and marketing, locally or across the globe. Asset sales, mergers and corporate take-overs are...
| 
| Valuation in Life Sciences: A Practical Guide
by Boris Bogdan (Author), Ralph Villiger (Author)
This book is the first complete guide to valuation in life sciences for industry professionals, investors, and academics. Boris Bogdan and Ralph Villiger introduce the characteristics of drug and medical device development, explain how to translate these into the valuation, and provide valuable industry data. After guiding the reader through the theory of valuation, including discounted cash-flow and real options, the authors demonstrate how to value projects, patents, licences, firms and...
|
|
|
